Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Buy
92
+26
+39% +$2.8K ﹤0.01% 2889
2026
Q1
$6.76K Buy
66
+18
+38% +$1.83K ﹤0.01% 2928
2025
Q4
$4.83K Buy
48
+1
+2% +$99 ﹤0.01% 2855
2025
Q3
$4.07K Hold
47
﹤0.01% 2856
2025
Q2
$3.59K Buy
47
+17
+57% +$1.24K ﹤0.01% 2858
2025
Q1
$2.13K Buy
30
+29
+2,900% +$2.27K ﹤0.01% 2960
2024
Q4
$78 Sell
1
-8
-89% -$747 ﹤0.01% 3459
2024
Q3
$921 Buy
+9
New +$747 ﹤0.01% 3059

Other funds holding NUVL

Parallel Advisors's NUVL Position: Q2 2026 in Review

Parallel Advisors increased its Nuvalent (NUVL) stake by 39% in Q2 2026, buying an estimated $2.8K and bringing the position to 92 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

Parallel Advisors first reported a position in NUVL in Q3 2024 and has held it in 8 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Parallel Advisors held 92 shares of Nuvalent worth $11.4K as of Q2 2026.
  • Parallel Advisors bought 26 Nuvalent shares in Q2 2026, an estimated $2.8K.
  • Nuvalent made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2889 holding.
  • Parallel Advisors first reported a position in Nuvalent in Q3 2024 and has held it in 8 quarters since.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.